Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05433519 · ClinicalTrials.gov registry record
Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 400
- Enrollment target
NCT05433519: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT05433519 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05433519 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
This is a prospective cohort study of women enrolled early in pregnancy, with randomization to determine the timing of three follow-up visits in the second and third trimester. At each of these follow-up visits, investigators will assess gestational age with the FAMLI technology and compare that estimate to the known gestational age established early in pregnancy.
Primary Outcome
Difference in mean absolute error (MAE) of the index test and clinical reference standard in the primary evaluation window
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-07-27 |
| Est. Completion | 2023-11-13 |
What the finished NCT05433519 record still lists
NCT05433519 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05433519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05433519 about?
NCT05433519 is a clinical study titled "Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age". This is a prospective cohort study of women enrolled early in pregnancy, with randomization to determine the timing of three follow-up visits in the second and third trimester. At each of these follow-up visits, investigators will assess gestational age with the FAMLI technology and compare that est...
What is the current status of trial NCT05433519?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2022-07-27. Estimated completion is 2023-11-13.
Who is sponsoring clinical trial NCT05433519?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI